Video

Dr. Anwer on the Efficacy of CAR T-Cell Therapy in Multiple Myeloma

Author(s):

Faiz Anwer, MD, discusses the efficacy of CAR T-cell therapy in multiple myeloma.

Faiz Anwer, MD, oncologist, physician-scientist, and stem cell transplant staff physician at the Taussig CancerInstituteof Cleveland Clinic; a member of the Hematopoietic and Immune Cancer Biology Program at Case Comprehensive Cancer Center; and an associate professor in the Department of Medicine at the School of Medicine at Case Western Reserve University, discusses the efficacy of CAR T-cell therapy in multiple myeloma.

CAR T-cell therapy has demonstrated some unique advantages over other available treatmentsfor patients withmultiple myeloma, says Anwer. One of these advantages is the matter of targeted specificity, which has been observed in numerous monoclonal antibodies. There is also an advantage in the cytotoxicity of a CAR T-cell–based therapy.

This combination of specificity and cytotoxicity has resulted in very high objective response rates in this patient population, Anwer concluded.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity